Liver micro flow MRI for liver health
Part of Digestive system clinical trials.
This study uses a new MRI technique to look at blood flow and iron in the liver, without needing a biopsy. It tests how well this newer imaging method works in people with liver disease and in healthy volunteers, to help improve diagnosis and monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 7 years old.
- You are able to lie still for an MRI scan (some metal implants or claustrophobia may be a problem).
- You are not pregnant or trying to become pregnant.
- You have not had a Ferumoxytol (an MRI contrast agent) injection in the past year.
- You either have a liver condition (like fatty liver, fibrosis, or cirrhosis) or are a healthy volunteer.
- If you take beta blockers, you must be willing to stop them for 3 days before the study (with your doctor's approval).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at MRI images taken as part of routine care to see if they can help predict future health problems in people with liver disease. If you already have an MRI scheduled for clinical reasons, this may help doctors better estimate risk over time.
This study tests whether a special MRI scan (called 4D-MRI) can identify liver scarring or damage. It may help doctors measure liver fibrosis and inflammation without relying only on invasive tests.
This study uses MRI imaging and computer modeling to better plan liver surgery and related liver treatments. It may help doctors predict circulation (blood flow) changes during surgery and choose safer surgical timing or approaches.
This study uses an automated MRI scan to measure things in the liver, such as liver fat and iron levels. It may help researchers better understand liver changes and improve how these measurements are done.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.